Pediatric Oncologist and Wheeling's Histrionic Brewlab co-founder hosts fundraiser to support Camp One Step
On Wednesday, May 24, Wheeling-based Histrionic Brewlab celebrated Illinois Craft Beer Week by partnering with District Brew Yards to raise funds for Camp One Step by Children's Oncology Services, a Chicago nonprofit that provides free year-round camp experiences for children with cancer and their families in an effort to foster joy, belonging, confidence, and lifelong friendships.
For Histrionic Brewlab's co-founder Jenn Schneiderman, Camp One Step's mission holds a deep, personal significance. By day, Schneiderman has been a pediatric oncologist who specializes in bone marrow and stem cell transplants for over 20 years.
Jenn founded Histrionic Brewlab with her husband, Lincoln, 12 years ago after working tirelessly to perfect their home brews on their back porch. Starting in 2019, Histrionic Brewlab was brewed out of brewery incubator, Pilot Project, in Logan Square. The brewery moved to District Brew Yards in Wheeling in 2022, the newest location for the collective brewery, which provides production and taproom space for emerging brewers.
"In the time I've been a formal member of the Illinois craft brewing community, I've been touched by the countless ways that local breweries give back and inspire change in their neighborhoods," said Schneiderman. "Our first fundraiser this week was a unique opportunity to support a profoundly important cause while doing what we love to do - brew exceptional craft beer. We're so grateful for all the support of our fellow brewers and the craft beer enthusiasts throughout the Chicago area."
As part of Histrionic Brewlab's fundraiser on Wednesday, May 24 $0.10 for every ounce of any beer purchased at District Brew Yards' West Loop location was directed to Camp One Step, resulting in thousands of dollars for the nonprofit. The funds raised will support Camp One Step's free in-person camps and digital programs that serve children with cancer as well as siblings, parents, and survivors.